[1] Thijs RD, Surges R, O'Brien TJ, Sander JW. Epilepsy in adults[J]. Lancet, 2019, 393:689-701. [2] China Association Against Epilepsy. Clinical diagnosis and treatment guidelines:epilepsy volume (2015 revised edition)[M]. Beijing:People's Medical Publishing House, 2015[.中国抗癫痫协会. 临床诊疗指南:癫痫病分册(2015修订版)[M].北京:人民卫生出版社, 2015.] [3] Covanis A. Epileptic encephalopathies (including severe epilepsy syndromes)[J]. Epilepsia, 2012, 53 Suppl 4:114-126. [4] Collins FS, Varmus H. A new initiative on precision medicine[J]. N Engl J Med, 2015, 372:793-795. [5] Li J, Cai T, Jiang Y, Chen H, He X, Chen C, Li X, Shao Q, Ran X, Li Z, Xia K, Liu C, Sun ZS, Wu J. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database[J]. Mol Psychiatry, 2016, 21:290-297. [6] Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM. ILAE classification of the epilepsies:position paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia, 2017, 58:512-521. [7] Lang Y, Wang XF, Yin J, Yu HJ, Zhang H. Advances in ion channel genes and genetics of epilepsy[J]. Zhonghua Shen Jing Ke Za Zhi, 2018, 51:642-648[.郎悦, 王小峰, 尹剑, 余浩佳, 张慧. 离子通道与癫痫遗传学研究进展[J]. 中华神经科杂志, 2018, 51:642-648.] [8] Xiong J, Yin F. Potassium ion channels and epilepsy[J]. Zhongguo Yi Shi Za Zhi, 2019, 21:1281-1286[.熊娟, 尹飞. 钾离子通道相关癫痫[J]. 中国医师杂志, 2019, 21:1281-1286.] [9] Lee IC, Chen JY, Chen YJ, Yu JS, Su PH. Benign familial neonatal convulsions:novel mutation in a newborn[J]. Pediatr Neurol, 2009, 40:387-391. [10] Brown DA, Passmore GM. Neural KCNQ (Kv7) channels[J]. Br J Pharmacol, 2009, 156:1185-1195. [11] Miceli F, Soldovieri MV, Ambrosino P, Barrese V, Migliore M, Cilio MR, Taglialatela M. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v) 7.2 potassium channel subunits[J]. Proc Natl Acad Sci USA, 2013, 110:4386-4391. [12] Orhan G, Bock M, Schepers D, Ilina EI, Reichel SN, Löffler H, Jezutkovic N, Weckhuysen S, Mandelstam S, Suls A, Danker T, Guenther E, Scheffer IE, De Jonghe P, Lerche H, Maljevic S. Dominant -negative effects of KCNQ2 mutations are associated with epileptic encephalopathy[J]. Ann Neurol, 2014, 75:382-394. [13] Villa C, Combi R. Potassium channels and human epileptic phenotypes:an updated overview[J]. Front Cell Neurosci, 2016, 10:81. [14] Trimmer JS. Subcellular localization of K + channels in mammalian brain neurons:remarkable precision in the midst of extraordinary complexity[J]. Neuron, 2015, 85:238-256. [15] Allen NM, Weckhuysen S, Gorman K, King MD, Lerche H. Genetic potassium channel -associated epilepsies:clinical review of the KV family[J]. Eur J Paediatr Neurol, 2020, 24:105-116. [16] Marini C, Romoli M, Parrini E, Costa C, Mei D, Mari F, Parmeggiani L, Procopio E, Metitieri T, Cellini E, Virdò S, De Vita D, Gentile M, Prontera P, Calabresi P, Guerrini R. Clinical features and outcome of 6 new patients carrying de novo KCNB1 gene mutations[J]. Neurol Genet, 2017, 3:e206. [17] Bar C, Barcia G, Jennesson M, Le Guyader G, Schneider A, Mignot C, Lesca G, Breuillard D, Montomoli M, Keren B, Doummar D, Billette de Villemeur T, Afenjar A, Marey I, Gerard M, Isnard H, Poisson A, Dupont S, Berquin P, Meyer P, Genevieve D, De Saint Martin A, El Chehadeh S, Chelly J, Guët A, Scalais E, Dorison N, Myers CT, Mefford HC, Howell KB, Marini C, Freeman JL, Nica A, Terrone G, Sekhara T, Lebre AS, Odent S, Sadleir LG, Munnich A, Guerrini R, Scheffer IE, Kabashi E, Nabbout R. Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies:27 new patients and overview of the literature[J]. Hum Mutat, 2020, 41:69-80. [18] Kang SK, Vanoye CG, Misra SN, Echevarria DM, Calhoun JD, O'Connor JB, Fabre KL, McKnight D, Demmer L, Goldenberg P, Grote LE, Thiffault I, Saunders C, Strauss KA, Torkamani A, van der Smagt J, van Gassen K, Carson RP, Diaz J, Leon E, Jacher JE, Hannibal MC, Litwin J, Friedman NR, Schreiber A, diversity of electrical signalling[J]. J Physiol, 2012, 590:2591-Lynch B, Poduri A, Marsh ED, Goldberg EM, Millichap JJ, 2599. George AL Jr, Kearney JA. Spectrum of K V 2.1 dysfunction in KCNB1-associated neurodevelopmental disorders[J]. Ann Neurol, 2019, 86:899-912. [19] Torkamani A, Bersell K, Jorge BS, Bjork RL Jr, Friedman JR, Bloss CS, Cohen J, Gupta S, Naidu S, Vanoye CG, George AL Jr, Kearney JA. De novo KCNB1 mutations in epileptic encephalopathy[J]. Ann Neurol, 2014, 76:529-540. [20] de Kovel CGF, Syrbe S, Brilstra EH, Verbeek N, Kerr B, Dubbs H, Bayat A, Desai S, Naidu S, Srivastava S, Cagaylan H, Yis U, Saunders C, Rook M, Plugge S, Muhle H, Afawi Z, Klein KM, Jayaraman V, Rajagopalan R, Goldberg E, Marsh E, Kessler S, Bergqvist C, Conlin LK, Krok BL, Thiffault I, Pendziwiat M, Helbig I, Polster T, Borggraefe I, Lemke JR, van den Boogaardt MJ, Møller RS, Koeleman BPC. Neurodevelopmental disorders caused by de novo variants in KCNB1 genotypes and phenotypes[J]. JAMA Neurol, 2017, 74:1228-1236. [21] Bhattacharjee A, Gan L, Kaczmarek LK. Localization of the Slack potassium channel in the rat central nervous system[J]. J Comp Neurol, 2002, 454:241-254. Bayly [22] Møller RS, Heron SE, Larsen LH, Lim CX, Ricos MG, MA, van Kempen MJ, Klinkenberg S, Andrews I, Kelley K, Ronen GM, Callen D, McMahon JM, Yendle SC, Carvill GL, Mefford HC, Nabbout R, Poduri A, Striano P, Baglietto MG, Zara F, Smith NJ, Pridmore C, Gardella E, Nikanorova M, Dahl HA, Gellert P, Scheffer IE, Gunning B, Kragh-Olsen B, Dibbens LM. Mutations in KCNT1 cause a spectrum of focal epilepsies[J]. Epilepsia, 2015, 56:e114-120. E, Licchetta [23] Heron SE, Smith KR, Bahlo M, Nobili L, Kahana L, Oliver KL, Mazarib A, Afawi Z, Korczyn A, Plazzi G, Petrou S, Berkovic SF, Scheffer IE, Dibbens LM. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy[J]. Nat Genet, 2012, 44:1188-1190. [24] Chen Y, Bao XH, Zhang QP, Wang JP, Wen YX, Yu SJ, Zhao Y. Genetic and clinical analysis of children with early-onset epilepsy encephalopathy caused by KCNT1 gene mutation[J]. Zhonghua Er Ke Za Zhi, 2018, 56:824-828[.陈岩, 包新华, 章清萍, 王佳平, 文泳欣, 于淑杰, 赵滢. KCNT1基因变异导致的早发性癫痫脑病患儿遗传学和临床分析[J]. 中华儿科杂志, 2018, 56:824-828.] [25] Yoshitomi S, Takahashi Y, Yamaguchi T, Oboshi T, Horino A, Ikeda H, Imai K, Okanishi T, Nakashima M, Saitsu H, Matsumoto N, Yoshimoto J, Fujita T, Ishii A, Hirose S, Inoue Y. Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations[J]. Epileptic Disord, 2019, 21:48-54. [26] Chong PF, Nakamura R, Saitsu H, Matsumoto N, Kira R. Ineffective quinidine therapy in early onset epileptic encephalopathy with KCNT1 mutation[J]. Ann Neurol, 2016, 79:502-503. PA, Tempel [27] Wang H, Kunkel DD, Martin TM, Schwartzkroin BL. Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons[J]. Nature, 1993, 365:75-79. [28] Wang H, Kunkel DD, Schwartzkroin PA, Tempel BL. Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain[J]. J Neurosci, 1994, 14:4588-4599. [29] Paulhus K, Ammerman L, Glasscock E. Clinical spectrum of KCNA1 mutations:new insights into episodic ataxia and epilepsy comorbidity[J]. Int J Mol Sci, 2020, 21:2802. [30] Jan LY, Jan YN. Voltage-gated potassium channels and the diversity of electrical signalling[J]. J Physiol, 2012, 590:2591-2599. [31] Dodson PD, Forsythe ID. Presynaptic K+ channels:electrifying regulators of synaptic terminal excitability[J]. Trends Neurosci, 2004, 27:210-217. [32] Chiu SY, Zhou L, Zhang CL, Messing A. Analysis of potassium channel functions in mammalian axons by gene knockouts[J]. J Neurocytol, 1999, 28:349-364. [33] Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, Schwartzkroin PA, Messing A, Tempel BL. Deletion of the K (V)1.1 potassium channel causes epilepsy in mice[J]. Neuron, 1998, 20:809-819. [34] Glasscock E, Qian J, Yoo JW, Noebels JL. Masking epilepsy by combining two epilepsy genes[J]. Nat Neurosci, 2007, 10:1554- 1558. [35] Ambrosino P, Soldovieri MV, Bast T, Turnpenny PD, Uhrig S, Biskup S, Döcker M, Fleck T, Mosca I, Manocchio L, Iraci N, Taglialatela M, Lemke JR. De novo gain-of- function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy[J]. Ann Neurol, 2018, 83:1198-1204. [36] Gururaj S, Palmer EE, Sheehan GD, Kandula T, Macintosh R, Ying K, Morris P, Tao J, Dias KR, Zhu Y, Dinger ME, Cowley MJ, Kirk EP, Roscioli T, Sachdev R, Duffey ME, Bye A, Bhattacharjee A. A de novo mutation in the sodium-activated potassium channel KCNT2 alters ion selectivity and causes epileptic encephalopathy[J]. Cell Rep, 2017, 21:926-933. [37] Mao X, Bruneau N, Gao Q, Becq H, Jia Z, Xi H, Shu L, Wang H, Szepetowski P, Aniksztejn L. The epilepsy of infancy with migrating focal seizures:identification of de novo mutations of the KCNT2 gene that exert inhibitory effects on the corresponding heteromeric K Na 1.1/K Na 1.2 potassium channel[J]. Front Cell Neurosci, 2020, 14:1. [38] Brenner R, Wilcox KS. Potassium channelopathies[M]//Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV. Jasper's basic mechanisms of the epilepsies. 4th ed. Bethesda (MD):National Center for Biotechnology Information (US), 2012. [39] Zhou Y, Yang H, Cui J, Lingle CJ. Threading the biophysics of mammalian Slo1 channels onto structures of an Slo1 channel[J]. J Gen Physiol, 2017, 149:985-1007. [40] Du W, Bautista JF, Yang H, Diez-Sampedro A, You SA, Wang L, Kotagal P, Lüders HO, Shi J, Cui J, Richerson GB, Wang QK. Calcium-sensitive potassium epilepsy and paroxysmal movement disorder[J]. Nat Genet, 2005, 37:733-738. [41] Lee US, Cui J. β subunit-specific function by a mutation associated with epilepsy and dyskinesia[J]. J Physiol, 2009, 587(Pt 7):1481-1498. [42] Ermolinsky B, Arshadmansab MF, Pacheco Otalora LF, Zarei MM, Garrido-Sanabria ER. Deficit of Kcnma1 mRNA expression in the dentate gyrus of epileptic rats[J]. Neuroreport, 2008, 19:1291-1294. [43] Karschin C, Dissmann E, Stühmer W, and GIRK(1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain[J]. J Neurosci, 1996, 16:3559-3570. [44] Jabs R, Seifert G, Steinhäuser C. Astrocytic function and its alteration in the epileptic brain[J]. Epilepsia, 2008, 49 Suppl 2:3-12. [45] Chever O, Djukic B, McCarthy KD, Amzica F. Implication of Kir4.1 channel in excess potassium clearance:an in vivo study on anesthetized glial-conditional Kir4.1 Neurosci, 2010, 30:15769-15777. [46] Ambrosini E, Sicca F, Brignone MS, D'Adamo MC, Napolitano C, Servettini I, Moro F, Ruan Y, Guglielmi L, Pieroni S, Servillo G, Lanciotti A, Valvo G, Catacuzzeno L, Franciolini F, Molinari P, Marchese M, Grottesi A, Guerrini R, Santorelli FM, Priori S, Pessia M. Genetically induced dysfunctions of Kir2.1 channels:implications for short QT3 syndrome and autism-epilepsy phenotype[J]. Hum Mol Genet, 2014, 23:4875-4886. [47] Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes:new clinical syndromes, new scientific insights, and new therapy[J]. Diabetes, 2005, 54:2503-2513. [48] Huang CW, Huang CC, Cheng JT, Tsai JJ, Wu SN. Glucose and hippocampal neuronal excitability:role of ATP-sensitive potassium channels[J]. J Neurosci Res, 2007, 85:1468-1477. [49] Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S, Inagaki N. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure[J]. Science, 2001, 292:1543-1546. [50] Hernández-Sánchez C, Basile AS, Fedorova I, Arima H, Stannard B, Fernandez AM, Ito Y, LeRoith D. Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death[J]. Proc Natl Acad Sci USA, 2001, 98:3549-3554. |